Overview
R-CHOP + GM-CSF for Previously Untreated LCL in Elderly
Status:
Completed
Completed
Trial end date:
2010-11-01
2010-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Patients will receive 6 to 8 cycles of R-CHOP (Rituximab, Cyclophosphamide, doxorubicin, vincristine, and prednisone), with GM-CSF.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of Wisconsin, Madison
Criteria
Inclusion Criteria:- Histologically confirmed, CD20+ B cell diffuse large cell lymphoma, with measurable or
evaluable disease
- Having no prior chemotherapy, immunotherapy or radiotherapy except for one cycle of
CHOP or R-CHOP.
Exclusion Criteria:
- Pregnant
- Hepatitis B Surface Antigen positive
- Have known CNS disease or HIV infection
- Have NY Classification III or IV disease.